SCHEMBL29979758

SCHEMBL29979758

Cc1cc([C@@]2(CNC(=O)OC(C)(C)C)NC(=O)NC2=O)n(C)n1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADAMTS5 Q9UNA0 7/20 0.39
ADAMTS4 O75173 6/20 0.39
MMP13 P45452 6/20 0.39
MMP14 P50281 6/20 0.39
MMP2 P08253 5/20 0.39
MMP3 P08254 5/20 0.39
ADAMTS7 Q9UKP4 12/20 0.39
ADAM17 P78536 6/20 0.37
ADAM10 O14672 1/20 0.37
MMP12 P39900 1/20 0.37
MMP15 P51511 1/20 0.37
ADAMTS12 P58397 1/20 0.37
ADAM8 P78325 1/20 0.37
MMP1 P03956 3/20 0.35
MMP7 P09237 3/20 0.35
MMP9 P14780 3/20 0.35
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24927861 1.00 ADAMTS5 (0.39) ADAMTS5ADAMTS4MMP13MMP14MMP2
SCHEMBL23354293 0.85 ADAMTS5 (0.43) ADAMTS5ADAMTS4MMP13MMP14MMP2
SCHEMBL29873578 0.82 ADAMTS5 (0.55) ADAMTS5ADAMTS4MMP13MMP14MMP2
SCHEMBL23384603 0.82 ADAMTS5 (0.55) ADAMTS5ADAMTS4MMP13MMP14MMP2
SCHEMBL24927841 0.80 ADAMTS7 (0.36) ADAMTS5ADAMTS4MMP13MMP14MMP2
SCHEMBL29979335 0.80 ADAMTS7 (0.40) ADAMTS5ADAMTS4MMP13MMP14MMP2
SCHEMBL23354518 0.80 ADAMTS7 (0.36) ADAMTS5ADAMTS4MMP13MMP14MMP2
SCHEMBL24927827 0.80 ADAMTS7 (0.54) ADAMTS5ADAMTS4MMP13MMP14MMP2
SCHEMBL24927728 0.80 ADAMTS7 (0.40) ADAMTS5ADAMTS4MMP13MMP14MMP2
SCHEMBL29979205 0.80 ADAMTS7 (0.36) ADAMTS5ADAMTS4MMP13MMP14MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12398120-B2 Substituted hydantoinamides as ADAMTS7 antagonists BAYER AKTIENGESELLSCHAFT (DE) 2025-08-26 US disclosed
EP-4058448-B1 HYDANTOIN DERIVATIVES AS ADAMTS7 ANTAGONISTS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER AG (DE) 2024-05-29 EP disclosed
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 US disclosed
EP-4058448-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer Aktiengesellschaft (DE) 2022-09-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12398120-B2 Substituted hydantoinamides as ADAMTS7 antagonists ADAMTS7, MMP7, ADAM17 ADAMTS5 7/4885ADAMTS4 6/4885MMP13 55/4885
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS ADAMTS7, MMP7, ADAM17 ADAMTS5 7/4885ADAMTS4 6/4885MMP13 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.